Nokota Management’s Pfizer PFE Stock Holding History

Nokota Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-137,547	Closed	-$4.59M	–	92
2016 Q2	$4.59M	Buy	+137,547	New	+$4.39M	0.17%	68

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nokota Management's PFE Position: Q4 2017 in Review

Nokota Management sold out of Pfizer (PFE) in Q4 2017, closing a stake of 582,994 shares — an estimated $19.7M sold.

Nokota Management first reported a position in PFE in Q3 2016 and held it in 5 quarters. The position peaked at $25.2M in Q1 2017. 2,243 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

Nokota Management reported no remaining Pfizer position as of Q4 2017 after selling out during the quarter.
Nokota Management sold 582,994 Pfizer shares in Q4 2017, an estimated $19.7M.
Nokota Management first reported a position in Pfizer in Q3 2016 and held it in 5 quarters.
Nokota Management's Pfizer position peaked at $25.2M in Q1 2017.
2,243 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on Nokota Management's 13F filing for Q4 2017, filed 14 Feb 2018.